In addition, 12 of the 13 cases of DLBCL/HGBCL‐MYC/BCL2 successfully investigated showed frequent somatic mutations in their rearranged immunoglobulin heavy chain variable (IGHV) genes (Figure 3A and supplementary material, Table S5). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.